Hepatitis A virus hemagglutination and a test for hemagglutination inhibition antibodies.

Abstract

Like enteroviruses, hepatitis A virus (HAV) hemagglutinated various species of erythrocytes under similar conditions. HAV-specific antibodies in both acute- and convalescent-phase sera were found to inhibit hemagglutination. The HAV hemagglutination inhibition test can be used for diagnosis, epidemiological surveillance, and vaccine assessment. 

Topics

3 Figures and Tables

Slides referencing similar topics